Viewing Study NCT05394103


Ignite Creation Date: 2025-12-24 @ 7:42 PM
Ignite Modification Date: 2025-12-30 @ 6:41 PM
Study NCT ID: NCT05394103
Status: RECRUITING
Last Update Posted: 2025-08-17
First Post: 2022-05-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
Sponsor: Qurient Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module